AU2530199A - Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods - Google Patents
Targeting immunoreagents useful in therapeutic and diagnostic compositions and methodsInfo
- Publication number
- AU2530199A AU2530199A AU25301/99A AU2530199A AU2530199A AU 2530199 A AU2530199 A AU 2530199A AU 25301/99 A AU25301/99 A AU 25301/99A AU 2530199 A AU2530199 A AU 2530199A AU 2530199 A AU2530199 A AU 2530199A
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic
- useful
- methods
- diagnostic compositions
- immunoreagents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2023398A | 1998-02-06 | 1998-02-06 | |
US09020233 | 1998-02-06 | ||
PCT/GB1999/000396 WO1999039748A1 (en) | 1998-02-06 | 1999-02-08 | Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2530199A true AU2530199A (en) | 1999-08-23 |
Family
ID=21797469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25301/99A Withdrawn AU2530199A (en) | 1998-02-06 | 1999-02-08 | Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2530199A (en) |
WO (1) | WO1999039748A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7700400A (en) * | 1999-10-06 | 2001-05-10 | Pharmacia Corporation | Uroguanylin as an intestinal cancer inhibiting agent |
US7067111B1 (en) | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
FR2805994A1 (en) * | 2000-03-10 | 2001-09-14 | Agronomique Inst Nat Rech | New compound for detecting and treating metastatic colorectal cancer comprises a conjugate of an STa peptide and an immunogenic protein which binds to the guanyl cyclase-c receptor |
GB0105224D0 (en) | 2001-03-02 | 2001-04-18 | Nycomed Amersham Plc | Improved peptide-chelate conjugates |
US20020197261A1 (en) * | 2001-04-26 | 2002-12-26 | Chun Li | Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use |
US7261875B2 (en) | 2001-12-21 | 2007-08-28 | Board Of Regents, The University Of Texas System | Dendritic poly (amino acid) carriers and methods of use |
US9050378B2 (en) | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
US10925977B2 (en) | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
US8735360B2 (en) | 2009-12-07 | 2014-05-27 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
US9617305B2 (en) | 2011-06-08 | 2017-04-11 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
US9527887B2 (en) | 2011-06-08 | 2016-12-27 | Ironwood Pharmaceutical, Inc. | Treatments for gastrointestinal disorders |
JP6874266B2 (en) * | 2017-09-22 | 2021-05-19 | 国立研究開発法人日本原子力研究開発機構 | Method for Synthesis of Tetraalkyl Nitriloacetamide Diacetamide Compound |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5367080A (en) * | 1990-11-08 | 1994-11-22 | Sterling Winthrop Inc. | Complexing agents and targeting radioactive immunoreagents useful in therapeutic and diagnostic imaging compositions and methods |
US6060037A (en) * | 1993-10-26 | 2000-05-09 | Thomas Jefferson University | Compositions that specifically bind to colorectal cancer cells and methods of using the same |
WO1999021587A1 (en) * | 1997-10-15 | 1999-05-06 | Nycomed Imaging As | Complexing agents and targeting immunoreagents |
-
1999
- 1999-02-08 AU AU25301/99A patent/AU2530199A/en not_active Withdrawn
- 1999-02-08 WO PCT/GB1999/000396 patent/WO1999039748A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999039748A1 (en) | 1999-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4217499A (en) | Composition having therapeutic and/or nutritionally active substituent | |
GB2331015B (en) | Therapeutic methods and compositions involving isoflavones | |
AU2655599A (en) | Endoluminal implant with therapeutic and diagnostic capability | |
AU3102097A (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
AU5526399A (en) | Improvements in or relating to the treatment of lesions | |
AU3762899A (en) | Training dummy assembly in human form | |
AU1884797A (en) | Improvements in or relating to contrast agents | |
AU4714797A (en) | Improvements in or relating to contrast agents | |
AU2790199A (en) | Biochemical compositions used in human treatment | |
AU9383098A (en) | Novel targeted contrast agents for diagnostic and therapeutic use | |
AU6721598A (en) | Dioxino derivatives and their use as therapeutic agents | |
AU3816697A (en) | Conservin compositions and therapeutic and diagnostic uses therefor | |
AU715620C (en) | Therapeutic methods and uses | |
AU8967998A (en) | Antibiotic-ligand conjugates and methods of use thereof | |
AU4215399A (en) | Dermatological compositions and methods | |
AU2530199A (en) | Targeting immunoreagents useful in therapeutic and diagnostic compositions and methods | |
AU3472799A (en) | Dermatological formulations and methods | |
AU3268197A (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
AU2087799A (en) | Diagnostic and therapeutic methods based upon valpha24jalphaq t cells | |
AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
AU6519899A (en) | Improvements in and relating to emitters | |
AU4629399A (en) | Substituted piperazones and their therapeutic uses | |
AU1978397A (en) | Urea nucleosides as therapeutic and diagnostic agents | |
AU5546898A (en) | Human lysosomal sialidase and therapeutic uses thereof | |
AU4003497A (en) | Therapeutic methods and compositions involving isoflavones |